Fertility, Pregnancy and — Contraception on Sorafenib

Yes, and your oncologist should discuss this with you before treatment begins, not after. Egg freezing (oocyte cryopreservation) and sperm banking are the two established options. How much time is available depends on how urgently treatment needs to start, which is a conversation for your oncologist and a fertility specialist together. A referral to a fertility specialist should happen at the time of diagnosis — before treatment begins — because these options become more complicated once sorafenib has started.

We do not yet have enough long-term data on sorafenib specifically to say with certainty. What is known is that the drug may affect fertility during treatment. Whether any change is permanent, partial, or fully reversible varies between individuals and depends on factors your oncologist and a fertility specialist can assess together. This is exactly why preserving eggs or sperm before starting is worth discussing early — it is the option available to you now, before treatment begins, not after.

The prescribing information for sorafenib requires women to use effective contraception for six months after the last dose, and men for three months. These periods reflect how long the drug and its active breakdown products remain in the body at levels that could affect a developing baby. Trying to conceive before these periods have passed carries a risk of harm to the fetus. Once the washout period ends, ask your oncologist whether attempting pregnancy is appropriate — the answer depends on where your cancer treatment stands, not only on drug clearance.

Your oncologist or a pharmacist will go through the options appropriate for you, because some hormonal methods interact with other medications you may be taking. Options generally considered highly effective include the copper IUD, a hormonal IUD, and injectable hormonal methods. Barrier methods alone are usually not considered sufficient as the only method on sorafenib. Do not change your contraception without discussing it with your treating team, and do not stop contraception before your oncologist confirms the washout period has passed.

Yes. Men on sorafenib are asked to use effective contraception if their partners could become pregnant, because the drug's active components can be present in semen. If your partner is already pregnant, tell your oncologist. Your team will advise on the precautions that apply for the rest of the pregnancy. Do not stop sorafenib on your own — the decision about how to proceed must involve your oncologist, who can weigh the risks on both sides.

This is a conversation worth having openly with your oncologist before treatment starts, not one to avoid. The requirement exists because sorafenib is known to harm a developing baby, and that risk does not change based on personal conviction. Your team will not judge your values, but they are obliged to explain the risk clearly. Whatever decision you make as a family, make it with full information — ask your oncologist to explain the known risks in as much detail as you need.